VLA1553-302

Clinical Trial Study App for the Valneva VLA1553-302 Vaccine study. This is a study to demonstrate lot-to-lot consistency of three lots of a live-attenuated Chikungunya virus. the app enables study participants to complete eDiary entries, view scheduled appointments, conduct video consultations, and access resources about the study.